NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ShanX Medtech

ShanX Medtech

Private
EindhovenHealthcare & Life Scienceshttps://shanxmedtech.com/

Last Round

Seed

Jan 7, 2026

Total Funding Raised

$25.71M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ShanX Medtech is a healthtech company that develops diagnostic platforms designed to accelerate antibiotic susceptibility testing and improve infection management.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Sensors, Health IoT

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Government Contracts

AI Layer

Non-AI

Keywords

point-of-care testingPOCTinfectious disease diagnosticsantimicrobial susceptibility testingASTmedical devicerapid diagnosticsdiagnostic hardwarephotonic sensorAMR surveillancebedside testingclinical diagnosticslab-on-a-chipusage-based billinghealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ShanX Medtech Comparables

Compare ShanX Medtech with similar companies based on industry and business-model similarity.

ShanX Medtech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Microplate Dx
80%
Ramja Genosensor
78%
First Light Diagnostics, Inc.
76%

ShanX Medtech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 7, 2026
SeedJul 3, 2025
GrantNov 17, 2022

Key People

Founding team and executive leadership

Sophia E. Shanko

Chief Executive Officer

Executive Team

Henk Stapert

Chief Technology Officer

Executive Team

ShanX Medtech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 9, 2026

    Grew 25% QoQ, from 12 to 15 employees.

  • Mar 22, 2026

    Grew 50% QoQ, from 10 to 15 employees.

ShanX Medtech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ShanX Medtech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ShanX Medtech's valuation, stock price, and market status.

Firmographic Details

HeadquartersEindhoven
Employee Range19
Year Founded2019
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.